Matica Biotechnology, a CDMO specialising in cell and gene therapies (CGT), has announced a strategic partnership with the National Center for Therapeutics Manufacturing (NCTM), part of the Texas A&M Engineering Experiment Station. The alliance is intended to provide an integrated
Matica Biotechnology (Matica Bio), a contract development and manufacturing organisation (CDMO) specialising in viral vector development, has announced a partnership with Treovir to address critical gaps in paediatric cancer care. Matica Bio will provide GMP manufacturing for clinical supplies of
Matica Biotechnology, a contract development and manufacturing organization (CDMO) specialising in viral vectors, has unveiled a new high-resolution ion-exchange chromatography (IEX) method designed to improve the analysis of AAV8 (Adeno-Associated Virus 8) viral vector capsids. This advancement addresses a key
Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) focusing on viral vector manufacturing, has entered into a strategic development partnership with CytoImmune, a biotechnology company based in Puerto Rico. This collaboration aims to advance a clinical
